Enlivex Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENLV and other ETFs, options, and stocks.About ENLV
Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state.
ENLV Key Statistics
Stock Snapshot
The current Enlivex Therapeutics(ENLV) stock price is $0.82, with a market capitalization of 20.09M. The stock trades at a price-to-earnings (P/E) ratio of -1.56.
On 2025-12-20, Enlivex Therapeutics(ENLV) stock traded between a low of $0.80 and a high of $0.86. Shares are currently priced at $0.82, which is +2.2% above the low and -5.0% below the high.
The Enlivex Therapeutics(ENLV)'s current trading volume is 574.84K, compared to an average daily volume of 941.45K.
In the last year, Enlivex Therapeutics(ENLV) shares hit a 52-week high of $2.10 and a 52-week low of $0.79.
In the last year, Enlivex Therapeutics(ENLV) shares hit a 52-week high of $2.10 and a 52-week low of $0.79.
ENLV News
Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...